MOREPEN LABORATORIES
Back to Income Statement
|
MOREPEN LABORATORIES Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,690 Cr | ₹1,418 Cr | ₹1,547 Cr | ₹1,188 Cr | ₹853 Cr |
What is the latest Revenue of MOREPEN LABORATORIES ?
Year | Revenue |
---|---|
Mar2024 | ₹1,690 Cr |
Mar2023 | ₹1,418 Cr |
Mar2022 | ₹1,547 Cr |
Mar2021 | ₹1,188 Cr |
Mar2020 | ₹853 Cr |
How is Revenue of MOREPEN LABORATORIES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹1,690 Cr | 19.25 | |
Mar2023 | ₹1,418 Cr | -8.36 | |
Mar2022 | ₹1,547 Cr | 30.20 | |
Mar2021 | ₹1,188 Cr | 39.27 | |
Mar2020 | ₹853 Cr | - |
Compare Revenue of peers of MOREPEN LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MOREPEN LABORATORIES | ₹2,918.1 Cr | -8.9% | -16.1% | -4.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,478.0 Cr | -6.5% | -4.7% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,845.0 Cr | -7.1% | -11.5% | 32.7% | Stock Analytics | |
CIPLA | ₹120,121.0 Cr | -4.3% | -0.1% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,327.0 Cr | -5.8% | 6.1% | 13.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,907.8 Cr | -5.8% | -6.8% | -11% | Stock Analytics |
MOREPEN LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MOREPEN LABORATORIES | -8.9% |
-16.1% |
-4.4% |
SENSEX | -1.2% |
-3.5% |
-0.5% |
You may also like the below Video Courses